FI981381A - Menetelmä HCV-polypeptidien valmistamiseksi - Google Patents

Menetelmä HCV-polypeptidien valmistamiseksi Download PDF

Info

Publication number
FI981381A
FI981381A FI981381A FI981381A FI981381A FI 981381 A FI981381 A FI 981381A FI 981381 A FI981381 A FI 981381A FI 981381 A FI981381 A FI 981381A FI 981381 A FI981381 A FI 981381A
Authority
FI
Finland
Prior art keywords
virus
polypeptides
hcv
hcv polypeptides
publication
Prior art date
Application number
FI981381A
Other languages
English (en)
Swedish (sv)
Other versions
FI105046B (fi
FI981381A0 (fi
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of FI981381A0 publication Critical patent/FI981381A0/fi
Priority claimed from PCT/US1990/001348 external-priority patent/WO1990011089A1/en
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of FI981381A publication Critical patent/FI981381A/fi
Application granted granted Critical
Publication of FI105046B publication Critical patent/FI105046B/fi

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI981381A 1989-03-17 1998-06-15 Menetelmä terapeuttisesti aktiivisen polypeptidin valmistamiseksi, rekombinanttivektori ja isäntäsolu FI105046B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32533889A 1989-03-17 1989-03-17
US32533889 1989-03-17
US9001348 1990-03-15
PCT/US1990/001348 WO1990011089A1 (en) 1989-03-17 1990-03-15 Nanbv diagnostics and vaccines

Publications (3)

Publication Number Publication Date
FI981381A0 FI981381A0 (fi) 1990-03-15
FI981381A true FI981381A (fi) 1998-06-15
FI105046B FI105046B (fi) 2000-05-31

Family

ID=23267470

Family Applications (1)

Application Number Title Priority Date Filing Date
FI981381A FI105046B (fi) 1989-03-17 1998-06-15 Menetelmä terapeuttisesti aktiivisen polypeptidin valmistamiseksi, rekombinanttivektori ja isäntäsolu

Country Status (3)

Country Link
DD (1) DD297446A5 (fi)
FI (1) FI105046B (fi)
RU (1) RU2204603C2 (fi)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent

Also Published As

Publication number Publication date
RU2204603C2 (ru) 2003-05-20
DD297446A5 (de) 1992-01-09
FI105046B (fi) 2000-05-31
FI981381A0 (fi) 1990-03-15

Similar Documents

Publication Publication Date Title
PT95329A (pt) Novos isolados de hcv
US5585258C1 (en) Hepatitus c virus protease
CA2012482A1 (en) Hepatitis c diagnostics and vaccines
EP0484787A3 (en) Hcv-specific peptides, process for obtaining them and their use
DK0992580T3 (da) Epitoper på human T-celler, som er immundominante for hepatitis C-virus
SG50563A1 (en) New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
CA2110058A1 (en) Hepatitis c virus (hcv) polypeptides
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
NO972264L (no) Fremgangsmåter for behandling av multippel sklerose ved bruk av peptidanaloger av human myelin basis protein
ATE171710T1 (de) Hcv peptidantigene und verfahren zur bestimmung von hcv
ATE309367T1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
DE69433160D1 (de) Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region
FI981381A (fi) Menetelmä HCV-polypeptidien valmistamiseksi
WO1995032290A3 (en) Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
DE69901099D1 (de) Verwendung von interferon alpha 5 in der behandlung viraler hepatopathien

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC.